S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
about
Herbal medicines and nonalcoholic fatty liver diseaseHepatic p63 regulates steatosis via IKKβ/ER stressHypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat DietThe Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial GenesPlasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris.Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liverMulti-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells.Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.S-adenosylmethionine Administration Attenuates Low Brain-Derived Neurotrophic Factor Expression Induced by Chronic Cerebrovascular Hypoperfusion or Beta Amyloid TreatmentIMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet.
P2860
Q26738524-15E0E40B-D681-4CAB-BA8D-B6F23B700E9EQ33654494-4EB49414-5DE1-4B46-9BFA-40CF14AE931CQ33884666-A1E215A9-E35A-43A5-9CA3-D17E17FA8C21Q35602046-18E4B242-D6BF-4FDF-BE8F-18A2307AC134Q36109119-C7B20517-3739-4591-97B9-65332EB2D489Q36476924-618D66A0-C5CA-452D-85D9-43B7A3D9ED38Q36877698-8AAE07EE-238B-435C-B76B-B556E8B60298Q36902259-40D01525-491B-48AF-8376-CAFB7FC73497Q37311340-21AAE9CD-7689-41CE-8250-D57CD6AC4749Q37598554-4D3ED843-CDF7-45FB-A496-5CD98AABCE2AQ40514578-E67E21E9-F79F-46C4-A821-D839A9D6F1B6Q41465656-E51643BF-BBD7-436D-AAA4-079153E2561CQ41627727-AD208CC4-25B4-4361-BD3C-051E3E6CAC45
P2860
S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
S-Adenosylmethionine increases ...... alcoholic fatty liver disease.
@ast
S-Adenosylmethionine increases ...... alcoholic fatty liver disease.
@en
type
label
S-Adenosylmethionine increases ...... alcoholic fatty liver disease.
@ast
S-Adenosylmethionine increases ...... alcoholic fatty liver disease.
@en
prefLabel
S-Adenosylmethionine increases ...... alcoholic fatty liver disease.
@ast
S-Adenosylmethionine increases ...... alcoholic fatty liver disease.
@en
P2093
P2860
P50
P1476
S-Adenosylmethionine increases ...... -alcoholic fatty liver disease
@en
P2093
Carmelo García-Monzón
Conrad Wagner
Daniela Mestre
David Fernandez-Ramos
José M Mato
Marta Varela-Rey
Olatz Fresnedo
Shelly C Lu
Virginia Gutiérrez-de Juan
Zigmund Luka
P2860
P304
P356
10.1016/J.JHEP.2014.10.019
P50
P577
2014-10-18T00:00:00Z